Ticagrelor versus clopidogrel in patients with STEMI treated with thrombolysis: the MIRTOS trial

Autor:	Lampros K. Michalis, Charalambos Karvounis, Vasilios Vasilikos, Dimitrios Stakos, Michalis Hamilos, Ioannis Anastasiou, Ioannis Tsiafoutis, Panos E. Vardas, John Kanakakis, George Hahalis, John A. Goudevenos, Konstantinos Raisakis, Michalis Koutouzis
Rok vydání:	2021
Předmět:	medicine.medical_specialty business.industry medicine.medical_treatment Percutaneous coronary intervention Thrombolysis 030204 cardiovascular system & hematology Clopidogrel 03 medical and health sciences 0302 clinical medicine Internal medicine Conventional PCI medicine Clinical endpoint Cardiology cardiovascular diseases 030212 general & internal medicine Cardiology and Cardiovascular Medicine business Ticagrelor Mace TIMI medicine.drug
Zdroj:	EuroIntervention. 16:1163-1169
ISSN:	1774-024X
DOI:	10.4244/eij-d-20-00268
Popis:	AIMS We aimed to demonstrate whether coronary microvascular function is improved after ticagrelor administration compared to clopidogrel administration in STEMI subjects undergoing thrombolysis. METHODS AND RESULTS MIRTOS is a multicentre study of ticagrelor versus clopidogrel in STEMI subjects treated with fibrinolysis. We enrolled 335 patients
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::12bec5f4ce8dc82b8faa6b2a672da70b https://doi.org/10.4244/eij-d-20-00268 Zobrazit plný text záznamu